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We examined associations of age at menarche and menstrual characteristics with the risk of preeclampsia among participants
(n = 3,365) of a pregnancy cohort study. Data were collected using in-person interviews and medical record abstraction. Logistic
regression was used to estimate adjusted odds ratio (OR) and 95% conﬁdence interval (95% CI). There was a signiﬁcant inverse
associationbetweenageatmenarcheandriskofpreeclampsia(P valuefortrend<0.05).Associationoflongcyclelength(>36days)
with higher risk of preeclampsia was present only among women who had prepregnancy body mass index <25kg/m2 (interaction
P value = 0.04). Early menarche is associated with higher risk of preeclampsia. Prepregnancy weight may modify associations of
long menstrual cycles with risk of preeclampsia.
1.Introduction
Menarche, an important milestone of sexual development,
signals the end of puberty and the beginning of reproductive
life in females [1, 2]. Both early and delayed menarche have
been associated with increased cardiovascular disease (CVD)
risk factors (including metabolic syndrome) and disease in
adolescent girls and young women [1, 3–7]. Further more,
women with long and irregular menstrual cycles have been
shown to have higher risk for CVD and type 2 diabetes
[5, 7, 8].
Preeclampsia, a multisystem pregnancy disorder, is char-
acterized by hypertension and proteinuria that develop after
20 weeks of gestation [9–14]. The precise pathophysiologic
mechanisms of preeclampsia remain unknown and are
subjectsofextensiveresearch[9–12,15–20].Sincepreviously
identiﬁed risk factors of preeclampsia (including maternal
obesity, insulin resistance, and other hormonal factors) [15,
18] are potentially associated with early menarche, delayed
menarche and/or menstrual irregularities [4, 5], age at
menarche, and menstrual characteristics may be associated
with risk of preeclampsia. Previous reports on associations
ofmenstrualcharacteristicswithpreeclampsiawerebasedon
case-control studies [5]. Among a well-characterized preg-
nancy cohort, we investigated relationships between age at
menarche and menstrual characteristics with risk of pree-
clampsia. We also examined whether prepregnancy body
mass index (BMI), adult weight gain, or maternal birth
weight, a marker of intrauterine development that has been
related to reproductive outcomes [21–24], modiﬁed these
associations.
2. Methods
2.1. Study Population. Study participants were drawn from
participants of the Omega study [9, 25]. Brieﬂy, the study
population comprised of women attending prenatal care
clinics aﬃliated with Swedish Medical Center (SMC) in
Seattle, WA, and Tacoma General Hospital (TGH) in
Tacoma, WA. Women were eligible if they initiated prenatal
care before 20 weeks of pregnancy, were >18 years old,2 ISRN Obstetrics and Gynecology
were able to speak and read English, plan to carry the
pregnancy to term, or planned to deliver at either of the
two research hospitals. During 1996–2008, 5,063 eligible
women were approached and 4,000 (79%) participants were
enrolled in the study. Of these, participants who moved
or delivered elsewhere (n = 151), delivered before 20
weeks (n = 43), had prior chronic hypertension (n =
167), and had no available information on menstrual age
(n = 274) or menstrual characteristics were excluded
from current analyses (n = 3,365). Study protocols
were approved by the Institutional Review Boards of SMC
and TGH. All participants provided written informed
consent.
2.2. Data Collection. Using standardized questionnaires ad-
ministered by a trained interviewer at or near the time of
enrollment, we gathered information on age at menarche,
menstrual characteristics, and other covariates including
maternal sociodemographic factors, medical/reproductive
histories, prepregnancy BMI, adult weight gain (diﬀerences
in weight at age 18 and prepregnancy weight), and maternal
birth weight. After delivery, maternal and infant medical
records were reviewed for information on the course and
outcomes of pregnancy.
Preeclampsia was deﬁned using American College of
Obstetricians and Gynecologists (ACOG) guidelines [26]a s
sustainedpregnancy-inducedhypertensionwithproteinuria.
Hypertension was deﬁned as sustained elevated blood pres-
sure (BP) readings of 140/90mmHg (with readings taking
place 6 hours apart) after 20 weeks of gestation. Proteinuria
was deﬁned as protein concentration of ≥30mg/dL on ≥2
random urine specimen collected 4 hours apart.
We gathered information on menstrual cycle character-
istics including (a) age at menarche (the interviewer asked
“At what age did you have your ﬁrst period?”), (b) irregular
menses after menarche (the interviewer asked “During the
ﬁrst year after starting your menstrual periods, did your
periods become regular? That is, could you predict within
one week when your next menstrual period would begin?”
and “Have your period ever been regular without using birth
control pills, injection, or implants?”), and (c) usual cycle
length(theinterviewerasked“Onaverage,howoftendidyou
have your menstrual period? That is, how many days were
there between the ﬁrst day of one menstrual period and the
ﬁrst day of the next?”).
2.3. Statistical Analysis. We examined general characteristics
of the study population using mean (standard deviation)
for continuous variables and numbers (%) for categorical
variables. We used unadjusted and multivariable adjusted
logistic regression analyses to compute odds ratio (OR)
and 95% conﬁdence interval (95% CI). We used ap r i o r i
identiﬁed indicator variables to categorize age at menarche
(≤11, 12 13, 14, and ≥15 years) and cycle length (≤24, 25–
30, 31–35, and ≥36 days) [5]. Categories of age 13 years and
25–30 days were used as references for age at menarche and
cycle length categories, respectively. Potential confounders
that resulted in >10% diﬀerence in estimated ORs (com-
paring unadjusted and adjusted regression coeﬃcients) were
considered as confounders and were retained in multivari-
able models. The ﬁrst adjusted model included variables for
maternal age, race/ethnicity, parity, maternal birth weight,
and pregestational diabetes. The second adjusted model
included variables for prepregnancy BMI in addition to
variables included in Model 1. We also evaluated potential
eﬀect modiﬁcation of the relationship between early age
at menarche and menstrual cycle length with preeclampsia
risk by prepregnancy overweight/obesity status (BMI ≥
25kg/m2), adult weight gain, and maternal birth weight.
For these analyses, we deﬁned early menarche as age at
menarche ≤11 years and long menstrual length as men-
strual cycle ≥36 days. We used both interaction terms
and stratiﬁed analyses to evaluate the presence of eﬀect
modiﬁcation [27]. All analyses were conducted using SPSS
version 14. Statistical signiﬁcance was deﬁned as two-sided
P<0.05.
3. Results
Participants, 32.6 years old on average, were predominantly
white (86.4%) (Table 1). Among 3,365 participants of the
cohort, 80 (2.4%) developed preeclampsia. We observed
a statistically nonsigniﬁcant higher risk of preeclampsia
(unadjusted OR: 1.56, 95% CI: 0.76–3.19) among partic-
ipants with long cycle length (≥36 days) compared with
participants with normal cycle length (25–30 days) (Table 2).
However, this relationship was not present after adjustment
for confounders. We did not ﬁnd associations of irregular
menses with risk of preeclampsia. There was a signiﬁcant
inverse association between age at menarche and risk of
preeclampsia (P value for trend < 0.05) (Table 2). While
the increased risk of preeclampsia associated with age at
menarche ≤11 years, compared with the referent (age
13), did not reach statistical signiﬁcance, women who had
menarche at ≤10 years of age (n = 8 preeclampsia cases
and n = 106 controls) had a 3-fold increase in risk of
preeclampsia compared with women who had menarche at
age 13 years (adjusted OR: 2.99, 95% CI 1.24–7.21) (not
shown).
In eﬀect modiﬁcation analyses, we observed signiﬁcant
interaction between prepregnancy BMI and cycle length
(P value for interaction = 0.04) (Table 3). The association
between longer cycle length and higher risk of preeclampsia
was present only among women who had prepregnancy
BMI < 25kg/m2 (OR: 2.56, 95% CI: 1.12–5.88) but not
among women who had prepregnancy BMI ≥ 25kg/m2
(OR: 0.44, 95% CI: 0.10–1.84). The association between
early age at menarche (≤11 years) and risk of preeclampsia
was signiﬁcantly higher and statistically signiﬁcant among
women who had birth weight ≥2.5kg (OR: 3.57, 95% CI:
1.07–11.93) compared with the association among women
who had birth weight <2.5kg (OR: 1.20, 95% CI: 0.45–
3.18), although the interaction term was not statistically
signiﬁcant (P value > 0.05). Women who were overweight
and had early menarche (≤11 years) had a 4-fold increase
in risk of preeclampsia compared with women who were
not overweight and had menarche after age 11 (95% CI:ISRN Obstetrics and Gynecology 3
Table 1: Age at menarche and selected characteristics of the study population.
Characteristics Entire cohort Age of menarche (years)
(n = 3365) ≤11 (n = 487) 12 (n = 881) 13 (n = 1048) 14 (n = 493) ≥15 (n = 456)
Maternal age, yearsa 32.6 ±4.53 1 .9 ±4.93 2 .6 ±4.53 2 .6 ±4.23 2 .7 ±4.33 3 .1 ±4.2
<20 20 (0.6) 9 (1.8) 1 (0.1) 6 (0.6) 2 (0.4) 2 (0.4)
20–34 2229 (66.2) 333 (68.4) 587 (66.6) 706 (67.4) 329 (66.7) 274 (60.1)
35+ 1116 (33.2) 145 (29.8) 293 (33.3) 336 (32.1) 162 (32.9) 180 (39.5)
Maternal White race 2909 (86.4) 380 (78) 752 (85.4) 922 (88) 447 (90.7) 408 (89.5)
Post-high-school education 3237 (96.2) 457 (93.8) 843 (95.7) 1016 (96.9) 478 (97) 443 (97.1)
Nulliparous 2138 (63.5) 309 (63.4) 559 (63.5) 686 (65.5) 301 (61.1) 283 (62.1)
Smoked during pregnancy 200 (5.9) 38 (7.8) 52 (5.9) 53 (5.1) 28 (5.7) 29 (6.4)
Prepregnancy BMI, kg/m2a 23.4 ±4.72 5 .3 ±5.92 3 .9 ±4.92 2 .9 ±4.12 2 .4 ±3.82 2 .3 ±3.9
<18.5 147 (4.4) 6 (1.2) 30 (3.4) 45 (4.3) 32 (6.5) 34 (7.5)
18.5–24.9 2434 (72.3) 293 (60.2) 607 (68.9) 799 (76.2) 379 (76.9) 356 (78.1)
25–29.9 526 (15.6) 109 (22.4) 167 (19) 137 (13.1) 63 (12.8) 50 (11)
30+ 258 (7.7) 79 (16.2) 77 (8.7) 67 (6.4) 19 (3.9) 16 (3.5)
Maternal birth weight (kg)a 3.3 ±(0.5) 3.2 ±(0.5) 3.3 ±(0.5) 3.3 ±(0.5) 3.3 ±(0.5) 3.3 ±0.6
<2.50 271 (8.1) 44 (9) 72 (8.2) 70 (6.7) 41 (8.3) 44 (9.6)
2.50–3.9 2735 (81.3) 403 (82.8) 704 (79.9) 861 (82.2) 405 (82.2) 362 (79.4)
>4.0 359 (10.7) 40 (8.2) 105 (11.9) 117 (11.2) 47 (9.5) 50 (11)
Polycystic ovary syndrome 95 (2.8) 12 (2.5) 32 (3.6) 17 (1.6) 18 (3.7) 16 (3.5)
FH of hypertension 1652 (49.1) 259 (53.2) 459 (52.1) 473 (45.1) 240 (48.7) 221(48.5)
FH of diabetes 488 (14.5) 86 (17.7) 126 (14.3) 149 (14.2) 63 (12.8) 64 (14)
Adult weight change, kga,b 7.5 ±1.09 .9 ±12.68 .1 ±10.86 .8 ±9.36 .2 ±8.56 .5 ±7.7
<−2.5 263 (7.9) 34 (7.1) 75 (8.6) 81 (7.8) 38 (7.8) 35 (7.8)
−2.5–2.5 773 (23.3) 92 (19.3) 197 (22.7) 260 (25.2) 126 (25.9) 98 (21.9)
2.5–4.9 553 (16.7) 73 (15.3) 138 (15.9) 165 (16.0) 101(20.7) 76 (17.0)
5.00–9.9 776 (23.4) 91 (19.1) 180 (20.7) 263 (25.5) 106 (21.8) 136 (30.4)
>10.0 948 (28.6) 187 (39.2) 278 (32.0) 264 (25.6) 116 (23.8) 103 (23.0)
Leisure time exercise during
pregnancy 2933 (87.2) 434 (89.1) 758 (86.0) 920 (87.8) 428 (86.8) 393 (86.2)
History of infertility problem 470 (14.0) 70 (14.4) 124 (14.1) 133 (12.7) 64 (13.0) 79 (17.3)
BMI 18 yearsa 20.6 ±2.92 1 .7 ±3.52 0 .9 ±2.82 0 .5 ±2.72 0 .1 ±2.61 9 .9 ±2.8
<18.5 615 (18.6) 53 (11.1) 136 (15.7) 174 (16.8) 120 (24.6) 132 (29.5)
18.5–24.9 2493 (75.2) 367 (76.8) 678 (78.2) 804 (77.7) 347 (71.3) 297 (66.3)
25.0–29.9 157 (4.7) 39 (8.2) 41 (4.7) 45 (4.3) 16 (3.3) 16 (3.6)
>30.0 50 (1.5) 19 (4.0) 12 (1.4) 12 (1.2) 4 (0.8) 3 (0.7)
aMean (SD) otherwise n (%).
bWeight change from age 18 to pregnancy.
BMI: body mass index (kg/m2), FH: family history.
2.24–8.66). Women who gained ≥5.0kg in adulthood and
did not have long cycles or early menarche had 4- to
5-fold higher risks of preeclampsia that were statistically
signiﬁcant compared with women who gained <5kg in
adulthood and did not have long cycles (OR: 4.33, 95%
CI: 1.63–11.45) or early age at menarche (OR: 5.28,
95% CI: 2.42–11.56), respectively (P values of interaction
> 0.05).
4. Discussion
We observed associations of early age at menarche with
increased risk of preeclampsia and evidence of eﬀect
modiﬁcation of the cycle length and risk of preeclampsia
association by maternal prepregnancy body mass index.
We also noted potential eﬀect modiﬁcations of the early
menarche and risk of preeclampsia association by maternal4 ISRN Obstetrics and Gynecology
Table 2: Association (odds ratio (OR), 95% (CI)) between menstrual cycle characteristics and risk of preeclampsia.
Characteristics Cases Noncases
Unadjusted Adjusted Model 1 Adjusted Model 2
OR 95% (CI) OR 95% (CI) OR 95% (CI)
Usual menstrual cycle length (days)
25–30 55 (68.8) 2383 (73.8) 1.00 Referent 1.00 Referent 1.00 Referent
<24 4 (5.0) 148 (4.6) 1.17 0.42–3.27 0.62 0.30–1.29 0.72 0.34–1.49
31–35 12 (15.0) 449 (13.9) 1.16 0.61–2.18 0.78 0.23–2.59 0.88 0.26–3.00
≥36 9 (11.3) 250 (7.7) 1.56 0.76–3.19 0.74 0.31–1.80 0.87 0.36–2.14
Irregular menses
No 67 (83.8) 2766 (85.2) 1.00 Referent 1.00 Referent 1.00 Referent
Yes 13 (16.3) 482 (14.8) 0.89 (0.49–1.63) 0.91 0.49–1.68 1.01 0.54–1.90
Age at menarche (years)
≤11 17 (21.3) 464 (14.3) 1.69 0.88–3.21 1.77 0.92–3.38 1.30 0.67–2.53∗
12 23 (28.8) 847 (26.1) 1.25 0.69–2.26 1.29 0.71–2.34 1.15 0.63–2.10∗
13 22 (27.5) 1015 (31.3) 1.00 Referent 1.00 Referent 1.00 Referent∗
14 10 (12.5) 480 (14.8) 0.96 0.45–2.04 0.97 0.45–2.08 1.01 0.47–2.18∗
≥15 8 (10.0) 442 (13.6) 0.83 0.36–1.89 0.83 0.36–1.90 0.93 0.41–2.12∗
Model 1 is adjusted for maternal age, race/ethnicity, parity, maternal birth weight, and pregestational diabetes.
Model 2 includes additional adjustment for maternal prepregnancy body mass index.
∗Trend P value < 0.05.
birth weight. Similarly, adult weight gain appeared to modify
the associations of age at menarche with risk of preeclampsia
and long menstrual cycles with risk of preeclampsia, though
these interactions were not statistically signiﬁcant.
Previously, early menarche (≤12 years) has been asso-
ciated with increased risk of CVD events [1]; investigators
have hypothesized that observed associations are poten-
tially mediated by increased adiposity associated with early
menarche [1]. In the current study, we found an inverse
relationship between age at menarche and increased risk
of preeclampsia. In a case-control study, also conducted in
Seattle, WA, Rudra and colleagues reported nonsigniﬁcant
3-fold increase in risk of preeclampsia among overweight
women with longer menstrual cycle length (OR: 3.11, 95%
CI: 0.62–15)[5], similar to our ﬁndings. The evidence from
the current study is stronger since it is based on a study
population from a prospective cohort study where maternal
recall of age at menarche and menstrual characteristics is
not inﬂuenced by the outcomes of the pregnancy. Previously,
adult weight gain of ≥10kg has also been associated with a
5-fold increased risk of preeclampsia (OR: 5.1, 95% CI: 2.2–
12.2) [25]. However, its role in the relationships of age at
menarche and cycle length with risk of preeclampsia has not
been well investigated. In the current study, we provide some
evidence of potential synergistic interactions between these
risk factors.
Girls who mature early (have early age at menarche)
tend to be heavier (overweight or obese) as adults [1, 6,
28]. It has been suggested that early maturing girls may
have a longer period of positive energy balance or other
endocrine factors that inﬂuence both the rate of sexual
maturation and the accumulation of body fat [6]. Obesity
is associated with cardiometabolic abnormalities, including
inﬂammation, and oxidative stress insulin resistance, which
have been related to preeclampsia and other pregnancy com-
plications. A number of biomarkers (e.g., C-reactive protein,
tumornecrosisalpha)orpathomechanisms(e.g.,endothelial
dysfunction and dyslipidemia) that have been shown to be
associated with both overweight/obesity status and pree-
clampsia support this evidence [4, 9, 16, 19, 28–30].
Birth weight is an indicator of intrauterine growth, a
period of critical growth and programming [21–24]. Thus,
maternal birth weight may be directly related to patho-
physiologic changes that occur during pregnancy, including
those that relate to risk of preeclampsia [21, 22]. In
addition, maternal birth weight may play an indirect role in
preeclampsia risk through its inﬂuence on other risk factors
of preeclampsia (e.g., obesity).
Some limitations of our study deserve mention. While
we collected and had access to information about maternal
characteristics and other covariates, we are aware of the fact
that self-reported medical histories may be subject to recall
bias and misclassiﬁcation. However, our prospective study
design would assure that the potential misclassiﬁcation is
not conditional on the diagnosis of preeclampsia. Although
we adjusted for several potential confounders, we cannot
exclude the possibility of residual confounding. Finally, we
cannot comment on the sequential inﬂuence of childhood
and pubertal obesity on menstrual characteristics and even-
tual risk of preeclampsia.
5. Conclusion
We have shown that early onset of menarche is associated
with an increased risk of preeclampsia and prepregnancy
weight modiﬁes associations of cycle length with risk of
preeclampsia. Prepregnancy weight, adult weight gain, and
maternal birth weight all appear to inﬂuence preeclampsiaISRN Obstetrics and Gynecology 5
Table 3: Menstrual characteristics, age at menarche, body weight measurements, and the risk of preeclampsia.
Stratifying covariates and exposure of interest Cases Noncases
Stratiﬁed by BMI Joint models
Adj. OR 95% (CI) Adj. OR 95% (CI)
Prepregnancy BMI and long cycle length1
<25kg/m2, <36 days 35 (43.8) 2327 (71.6) 1.00 Referent 1.00 Referent
<25kg/m2, ≥36 days 7 (8.8) 187 (5.8) 2.56 1.12–5.88 2.50 1.09–5.72
≥25kg/m2, <36 days 36 (45.0) 653 (20.1) 1.00 Referent 3.78 2.35–6.08
≥25kg/m2, ≥36 days 2 (2.5) 81 (2.5) 0.44 0.10–1.84 1.67 0.40–7.09
Prepregnancy BMI and early age at menarche
<25kg/m2, >11 years 37 (46.3) 2223 (68.4) 1.00 Referent Referent Referent
<25kg/m2, ≤11 years 5 (6.3) 291 (9.0) 1.13 0.44–2.92 1.08 0.42–2.76
≥25kg/m2, >11 years 26 (32.5) 561 (17.3) 1.00 Referent 2.86 1.71–4.77
≥25kg/m2, ≤11 years 12 (15.0) 173 (5.3) 1.48 0.72–3.02 4.41 2.24–8.66
Maternal birth weight and long cycle length
≥2500gr, <36 days 64 (80.0) 2755 (84.8) 1.00 Referent Referent Referent
≥2500gr, ≥36 days 7 (8.8) 225 (6.9) 1.36 0.61–3.00 1.36 0.31–3.00
<2500gr, <36 days 2 (2.5) 33 (1.0) 1.00 Referent 2.65 0.62–11.31
<2500gr, ≥36 days 7 (8.8) 235 (7.2) 0.53 0.10–2.84 1.28 0.58–2.83
Maternal birth weight and early age at menarche
≥2500gr, >11 years 57 (71.3) 2566 (79.0) 1.00 Referent Referent Referent
≥2500gr, ≤11 years 3 (3.8) 40 (1.2) 3.57 1.06–11.96 3.57 1.07–11.93
<2500gr, >11 years 6 (7.5) 218 (6.7) 1.00 Referent 1.26 0.54–2.95
<2500gr, ≤11 years 14 (17.5) 424 (13.1) 1.20 0.45–3.18 1.54 0.85–2.80
Adult weight gain2 and long usual cycle length
<5.0kg, <36 days 14 (17.5) 1441 (44.4) 1.00 Referent Referent Referent
<5.0kg, ≥36 days 3 (3.8) 122 (3.8) 2.71 0.76–9.72 2.47 0.70–8.73
≥5.0kg, <36 days 57 (71.3) 1539 (47.4) 1.00 Referent 3.87 2.14–6.98
≥5.0kg, ≥36 days 6 (7.5) 146 (4.5) 1.12 0.47–2.64 4.33 1.63–11.45
Adult weight gain and early age at menarche
<5.0kg, >11 years 13 (16.3) 1369 (42.2) 1.00 Referent Referent Referent
<5.0kg, ≤11 years 4 (5.0) 194 (6.0) 2.40 0.77–7.52 2.26 0.73–7.03
≥5.0kg, >11 years 50 (62.5) 1415 (43.6) 1.00 Referent 3.79 2.05–7.03
≥5.0kg, ≤11 years 13 (16.3) 270 (8.3) 1.36 0.47–2.64 5.28 2.41–11.56
All models are adjusted for age, race, family history of diabetes, and physical activity.
1Interaction P value 0.04.
2Adult weight gain: diﬀerence between weight at age 18 and prepregnancy weight.
risk associated with early age at menarche and longer
menstrual cycles. Future larger studies that investigate this
research area may create opportunities for prevention and
early intervention of preeclampsia.
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